Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-22
2008-07-22
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S447000, C514S326000, C549S060000, C549S063000
Reexamination Certificate
active
10730272
ABSTRACT:
Compounds represented by formula:wherein X, Y and Z are as defined herein, pharmaceutically acceptable salts thereof, and related compounds, are suitable for use in treating or preventing a Flaviviridae viral infection in a host.
REFERENCES:
patent: 4180662 (1979-12-01), Pfister et al.
patent: 6187799 (2001-02-01), Wood et al.
patent: 6380214 (2002-04-01), Gant et al.
patent: 6414013 (2002-07-01), Fancelli et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 6620767 (2003-09-01), Ducray et al.
patent: 6660728 (2003-12-01), Scheunemann et al.
patent: 6660732 (2003-12-01), Betageri et al.
patent: 6734207 (2004-05-01), Uckun et al.
patent: 6747057 (2004-06-01), Ruzafa et al.
patent: 6881741 (2005-04-01), Chan Chun Kong et al.
patent: 199 03 398 (2000-08-01), None
patent: 199 20 247 (2000-11-01), None
patent: 7-48360 (1995-02-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 02/28353 (2002-04-01), None
Roberts et al. “Preparation of nucleoside . . . ” CA 139:365176 (2003).
Hadziyannis et al. “Emerging treatments in chronic hepatitis B” CA 142:253391 (2004).
Sostegni et al. “wquential versis concomitant administration . . . ” CA 129:285628 (1998).
Vicari et al. “Safety, pharmacokinetics . . . ” CA 2007:977620 (2007).
David McKinnon et al., “The Conversions of Izothiazolium Salts into Thiophenecarboxylic Ester Derivatives”,Can. J. Chem., 1984, vol. 62, pp. 1580-1584.
Pilar Goya et al., Synthesis of 4-Oxo- 3,4-dihydro-1H-thieno [3,4-c] and thieno [3,2-c][1,2,6]thiadiazine 2,2-Dioxides,Synthesis, Apr. 1989, pp. 280-282.
Bo Sung Kim et al., “Reactions of ThiaroylketeneS,N-Acetals with 1,3-Dicarbonyl Compounds in the Presence of Mercury (II) Acetate: A General Route to 2-Acyl-and 2 Aroyl-3-(alkylamino)-5-arylthiopenes and 2-(Ethoxycarbonyl)-3-(methylamino)-5-arylthiopenes”,J. Org. Chem., 1998, vol. 63, pp. 6086-6087.
Bo Sung et al., “A Facile and Convenient Synthesis of 3-Alkylamino-5-arylthiopenes with a Variety of Substituents at C-2 and Studies of Reaction Mechanisms”,J. Org. Chem, 2000, vol. 65, pp. 3690-3699.
Ya. L. Gol'dfarb et al., “Action of Alkali Metals in Liquid Ammonia on Substituted Thiophenes. Communication 9. Preparation of 5-Mercapto-4-Ketoalkanoic Acids by Reductive Cleavage of 4-Acetylamino- and 4-Nitrothiphene-2-Carboxylic Acids”,Izv. Akad. NaukSSSR.Ser. Khim., 1984, vol. 10, pp. 2136-2139.
J. R. Desai et al.; J. Ind. Chem. Soc., vol. 74, 1997, p. 160, “Thieno[3,2-d]pyrimidines—Part-I: Preparation and Antimicrobial Activity of 3-N-Substituted-tioureido-2-methyl-6-phenylthieno[3,2-d]pyrimidin-4(3H)-ones”, ISR ref. XP002220249.
E. Marchand, G. Morel, Bull. Soc. Chim. Fr. vol. 133, No. 9, 1996, p. 903-912, “Alpha-Thioxothioamides Reactions de cycloaddition [4+2] avec l'acetylenedicarboxylate de dimethyle et le propiolate de methyle”, ISR ref. XP002220251.
W. Kantlehner et al., J. Prakt. Chem., vol. 338, 1996, p. 403-413; “Orthoamide, IL. Umsetzungen von Orthoamid-Derivaten mit Schwefel und Selen, Synthesen von 1,3-Thiazol- und 1,3-Selenazolderivaten” ISR ref. XP002220245.
S. Vega et al., Eur. J. Med. Chem. vol. 23, No. 4, 1988, p. 329-334; “Thiophene Isosteres: Synthesis and Pharmacological Study of 3-(azol-l-yl)thieno isothiazole-1,1-dioxides” ISR ref. XP002220246.
R.A. Smith et al., Bioorg. Med. Chem. Lett. vol. 11, No. 20, 2001, p. 2775-2778; “Discovery of Heterocyclic Ureas as a New Class of Raf Kinase Inhibitors: Identification of a Second Generation Lead by a Combinatorial Chemistry Approach”, ISR ref. XP001118699.
B.S. Kim et al., J. Org. Chem. vol. 63, No. 18, 1998, p. 6086-6087, “Reactions of Thioaroylketene S,N-Acetals with 1,3-Dicarbonyl Compounds in the Presence of Mercury(II) Acetate: A General Route to 2-Acyl- and 2-Aroyl-3-(alkylamino)-5-arylthiophenes and 2-(Etoxycarbonyl)-3-(methylamino)-5-arylthiophenes”; ISR ref. XP001118697.
A.M. Redman et al., Bioorg. Med. Chem. Lett., vol. 11, 2001, p. 9-12; “P38 Kinase Inhibitors for the Treatment of Arthritis and Osteoporosis: Thienyl, Furyl, and Pyrrolyl Ureas”, ISR ref. XP004225311.
D.J. Lee et al., Chemical Abstracts Service, Columbus, OH, U.S., “Novel Synthesis of 5,6-Dihydro-4H-thieno[3,2-b]pyrrol-5-ones via the Rhodium(II)-Mediated Wolff Rearrangement of 3-(2-Thienyl)-3-oxo-2-diazopropanoates”; Database accession No. 2002:151873, ISR ref. XP002220252.
M. Sugiyama et al., Chem. Pharm. Bull. vol. 37, No. 8, 1989, p. 2091-2102; “Condensed Thienopyrimidines. I. Synthesis and Gastric Antisecretory Activity of 2,3-Dihydro-5H-oxazolothienopyrimidin-5-one Derivatives”, ISR ref. XP001118351.
J.C. Lancelot et al., J. Heterocycl. Chem. vol. 33, No. 2, 1996, p. 427-430; “A Facile Synthesis of New Beta-Lactams”, ISR ref. XP002220247.
D.M. McKinnon et al., Can. J. Chem. vol. 62, No. 8, 1984, p. 1580-1584; “The Conversion of Isothiazolium Salts into Thiophenecarboxylic Ester Derivatives”, ISR ref. XP002220248.
J.R. Desai et al., J. Inst. Chemists (INDIA) vol. 67, 1995, p. 136-137, “Thieno[3,2-d]pyrimidines—Part-II: Preparation and Antimicrobial Activity of 2-methyl-3-N-Arylsulphonamido-6-Phenylthieno[3,2-d]Pyrimidin-4(3H)-ones”, ISR ref. XP002220249.
Co-pending U.S. Appl. No. 10/166,031, filed Jun. 11, 2002.
Co-pending U.S. Appl. No. 11/042,442, filed Jan. 26, 2005.
B.S. Kim, K. Kim; J. Org. Chem. vol. 65, No. 12, 2000, p. 3690-3699, “A Facile and Convenient Synthesis of 3-Alkylamino-5-Arylthiophenes with a Variety of Substituents at C-2 and Studies of Reaction Mechanisms”; ISR ref XP001118698.
J.R. Desai et al., J. Inst. Chemists (INDIA) vol. 67, 1995, p. 160, “Thieno[3,2-d]pyrimidines—Part-I: Preparation and Antimicrobial Activity of 2-methyl-3-N-Arylsulphonamido-6-Phenylthieno[3,2-d]Pyrimidin-4(3H)-ones”, ISR ref. XP002220250.
Chan Chun Kong Laval
Das Sanjoy Kumar
Halab Liliane
Ming-Qiang Zhang
Nguyen-Ba Nghe
Chang Celia
Millen White Zelano & Branigan P.C.
ViroChem Pharma Inc.
LandOfFree
Compounds and methods for the treatment or prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for the treatment or prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for the treatment or prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3954978